Skip to main content
. 2021 May 10;2021(5):CD013620. doi: 10.1002/14651858.CD013620.pub2

Laurent 1998.

Study characteristics
Methods Study objective: to assess the effectiveness of 3 prevention strategies and compare them to the standard mattress
Study design: randomised controlled trial
Study grouping: factorial design
Duration of follow‐up: mean length of stay 15.04 (SD 7.10)
Number of arms: 4
Single centre or multi‐site: single centre
Study start date and end date: not described
Setting: hospital
Participants Baseline characteristics
Inclusion criteria: adults over 15 years of age, admitted for major cardiovascular surgery, hospital stay likely to be at least 5 days, with a period on the intensive care unit (ICU)
Exclusion criteria: not reported
Sex (M:F): 214:98 across 4 groups
Age (years): mean 64.0 (SD 11.88) across 4 groups
Baseline skin status: not described
Group difference: no difference
Total number of participants: n = 312
Unit of analysis: individuals
Unit of randomisation (per patient): individuals
Interventions Intervention characteristics
Standard group
  • Description of interventions: standard mattress in ICU; standard mattress postoperatively

  • NPIAP S3I classification: standard hospital surface (ICU); standard hospital surface (postoperation)

  • Co‐interventions: not described

  • Number of participants randomised: n = 80

  • Number of participants analysed: n = 80


Alternating mattress in ICU
  • Description of interventions: Nimbus (AP) in ICU; standard mattress postoperatively

  • NPIAP S3I classification: powered, alternating pressure (active) air surface (ICU); standard hospital surface (postoperation)

  • Co‐interventions: not described

  • Number of participants randomised: n = 80

  • Number of participants analysed: n = 80


Constant low‐pressure mattress in postoperative hospitalisation
  • Description of interventions: standard mattress in ICU; Tempur (CLP) postoperatively (Laurent 1998). Additional source of information: "a visco‐elastic polyethylene urethane foam mattress (Tempur®, Tempur‐World Inc., USA)" (Vanderwee 2005).

  • NPIAP S3I classification: standard hospital surface (ICU); non‐powered reactive foam surface; high specification viscoelastic foam (postoperation)

  • Co‐interventions: not described

  • Number of participants randomised: n = 75

  • Number of participants analysed: n = 75


Both mattresses
  • Description of interventions: Nimbus in ICU and Tempur (CLP) postoperatively

  • NPIAP S3I classification: powered, alternating pressure (active) air surface (ICU); non‐powered, reactive foam surface; high specification viscoelastic foam (postoperation)

  • Co‐interventions: not described

  • Number of participants randomised: n = 77

  • Number of participants analysed: n = 77

Outcomes Proportion of participants developing a new pressure ulcer
  • Outcome type: binary

  • Time points: not described

  • Reporting: partially reported

  • Measurement method (e.g. scale, self‐reporting): assessed by specially trained nurses and classified as stage 0 (normal skin), stage 1 (non‐blanchable erythema), and stage 2 (partial or full thickness skin loss)

  • Definition (including ulcer stage): cumulative incidence of pressure sores of stage 2 (the lower the rate, the better the mattress effectiveness)

  • Drop outs: not described

  • Notes (e.g. other results reported): 45 of 312 (14.4%) having pressure sores; 14 of 80 in standard; 10 of 80 in alternating mattress in ICU; 11 of 75 in constant low pressure mattress; 10 of 77 in both mattresses


Time to pressure ulcer development
  • Reporting: not reported


Support‐surface‐associated patient comfort
  • Reporting: not reported


All reported adverse events using allocated support surfaces
  • Reporting: not reported


Health‐related quality of life (HRQOL)
  • Reporting: not reported


Cost‐effectiveness
  • Reporting: not reported

Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "Patients were randomised by blocks"
Comment: unclear risk of bias because the randomisation method was not stated.
Allocation concealment (selection bias) Unclear risk Comment: no information provided
Blinding of participants and personnel (performance bias)
All outcomes High risk Outcome group: primary outcome
Quote: "Given the kind of material tested, blinding was not possible"
Comment: high risk of bias as the above statement suggests.
Blinding of outcome assessment (detection bias)
All outcomes High risk Outcome group: primary outcome
Quote: "Given the kind of material tested, blinding was not possible"
Comment: high risk of bias as the above statement suggests.
Incomplete outcome data (attrition bias)
All outcomes Low risk Outcome group: primary outcome
Comment: no attrition identified.
Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre‐specified.
Other bias High risk Comment: the study appears not to consider the interaction between the effects of the different interventions that results from the factorial design used.